M Vaillant
Overview
Explore the profile of M Vaillant including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
332
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Masmoudi W, Vaillant M, Vassileva S, Patsatsi A, Quereux G, Moltrasio C, et al.
Br J Dermatol
. 2020 Oct;
184(6):1106-1112.
PMID: 33067805
Background: The Bullous Pemphigoid Disease Area Index (BPDAI) score has been proposed to provide an objective measure of bullous pemphigoid (BP) activity. Objectives: The objective of this study was to...
2.
Fays F, Palazzi P, Hardy E, Schaeffer C, Phillipat C, Zeimet E, et al.
Sci Total Environ
. 2020 Aug;
747:141185.
PMID: 32771784
In studies investigating the effects of endocrine disruptors (ED) such as phthalates, bisphenols and some pesticides on human health, exposure is usually characterized with urinary metabolites. The variability of biomarkers...
3.
Samouda H, De Beaufort C, Stranges S, Van Nieuwenhuyse J, Dooms G, Keunen O, et al.
Pediatr Diabetes
. 2016 Jul;
18(5):399-404.
PMID: 27400675
Background: The efficiency of traditional anthropometric measurements such as body mass index (BMI) or waist circumference (Waist C) used to replace biomedical imaging for assessing visceral adipose tissue (VAT) is...
4.
Horn S, Fournier-Bidoz N, Pernin V, Peurien D, Vaillant M, Dendale R, et al.
Cancer Radiother
. 2016 Mar;
20(2):98-103.
PMID: 26992750
Purpose: Second cancers and cardiovascular toxicities are long term radiation toxicity in locally advanced Hodgkin's lymphomas. In this study, we evaluate the potential reduction of dose to normal tissue with...
5.
Deroux A, Brion J, Hyerle L, Belbezier A, Vaillant M, Mosnier E, et al.
J Clin Virol
. 2014 Mar;
60(1):60-2.
PMID: 24583064
Hepatitis E (HEV) is an emerging disease in our developed countries, but is not routinely tested for in case of liver cytolysis. However, a growing number of extra-hepatic manifestations of...
6.
Droste D, Iliescu C, Vaillant M, Gantenbein M, De Bremaeker N, Lieunard C, et al.
Bull Soc Sci Med Grand Duche Luxemb
. 2013 Jul;
(1):28-38.
PMID: 23808108
Background: Healthy diet and physical activity improve risk factors for cerebrovascular disease. It is unclear whether patients with carotid artery disease from Luxemburg meet common guideline criteria and whether systematic...
7.
Franko B, Vaillant M, Recule C, Vautrin E, Brion J, Pavese P
Med Mal Infect
. 2013 Apr;
43(4):171-3.
PMID: 23622954
No abstract available.
8.
DAlessandro S, Basilico N, Corbett Y, Scaccabarozzi D, Omodeo-Sale F, Saresella M, et al.
Biochem Pharmacol
. 2011 Jun;
82(5):476-84.
PMID: 21684264
Artemisinin derivatives, the current cornerstone of malaria treatment, possess also anti-angiogenic and anti-tumor activity. Hypoxia plays a crucial role both in severe malaria (as a consequence of the cytoadherence of...
9.
Krudsood S, Looareesuwan S, Wilairatama P, Leowattana W, Tangpukdee N, Chalermrut K, et al.
Trop Med Int Health
. 2011 Jan;
16(4):458-65.
PMID: 21219551
Objective: To ascertain whether mefloquine (MQ) produces electrocardiogram (ECG) changes that could be a risk for Torsades de Pointe (TdP), a potentially malignant, ventricular tachyarrhythmia. Methods: We measured the Fridericia...
10.
Krudsood S, Looareesuwan S, Tangpukdee N, Wilairatana P, Phumratanaprapin W, Leowattana W, et al.
Antimicrob Agents Chemother
. 2010 Jun;
54(9):3730-7.
PMID: 20547795
A new fixed-dose artesunate (AS)-mefloquine (MQ) was assessed in adults hospitalized for 28 days with uncomplicated drug-resistant falciparum malaria. The patients (n = 25/arm) were treated with (i) two fixed-dose...